July 24, 2019

Olistica Life Sciences Group Chooses Nutrasource as Global Regulatory and Scientific Solutions Provider for Kratom and CBD Products

GUELPH, Ontario (July 24, 2019) – Olistica Life Sciences Group (Olistica), a global health product company, has chosen Nutrasource Pharmaceutical and Nutraceutical Services (Nutrasource), a full-service contract research organization (CRO), as their global regulatory and clinical scientific solutions provider for their cutting-edge product development within the kratom and cannabidiol (CBD) categories.

Both plant-sourced ingredients have unique pharmacological properties and require very nuanced scientific programs in order to be developed appropriately for regulatory compliance, authorization and approval. These ingredient categories are both highly stigmatized and controversial in both the scientific and regulatory domains. There are significant concerns about usage and safety globally, however Olistica is committed to showcasing the extensive therapeutic potential that these ingredients possess.

“Nutrasource applauds Olistica for developing these products at the appropriate level of diligence and within the correct regulatory pathways with an evidence-based approach,” says William Rowe, President and CEO of Nutrasource. “Kratom has huge therapeutic potential for various ailments, specifically in the area of opioid withdrawal, and as a result, could have huge positive social impact on the major issue of opioid dependence.”

“Olistica Life Sciences Group is excited to share its vision for the revitalization of plant-based therapeutics for use in modern medicine with Nutrasource,” states Mark Jennings, Chief Operating Officer at Olistica, “We are adamant about improving access to safe and efficacious botanicals that have massive opportunity to improve the health, well-being and quality of life for consumers globally.”

Botanicals, such as kratom, exist at the pharmaceutical and nutraceutical interface, and require rigorous scientific methods to be taken through the product development process from pharmacokinetics to commercialization. Olistica is determined to remain on the cutting-edge of innovation by leveraging Nutrasource’s industry-leading understanding of how to take botanicals through the pharmaceutical and nutraceutical pathways from concept to claim.


About Olistica Life Science

Olistica Life Sciences Group is a bioscience organization dedicated to the advancement of innovative, sustainable solutions derived from nature. Our primary goal is to improve the human experience through natural products or via pathways lent by nature. 


About Nutrasource

Nutrasource is a premier CRO that brings unparalleled expertise in nutrition, regulatory affairs, and pharmaceutical science to help clients achieve compliance and gain market entry for health products globally. With nearly 20 years' experience across the entire product spectrum from foods and supplements to pharmaceuticals, Nutrasource provides vertically-integrated solutions and unmatched scientific acumen in the pharmaceutical and nutraceutical industries to design and execute clinical trials as well as develop regulatory strategies that provide a unique advantage in product commercialization. No other CRO has the combination of personnel, with the breadth and depth of experience in both pharmaceutical development and natural health products, providing the leadership needed to launch products with strong science and regulatory confidence – from concept to claim. www.nutrasource.ca. 

For more information, please contact:

William Rowe, President and CEO, Nutrasource

1-519-341-3360 | info@nutrasource.ca | Contact Form